EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Aspergillus Section Flavi from Three French Hospitals

Elie Djenontin, Jean-Marc Costa, Bita Mousavi, Lin Do Ngoc Nguyen, Jacques Guillot, Laurence Delhaes iD, Françoise Botterel iD, Eric Dannaoui iD

Microorganisms · 28.09.2023 · 11 (10) · 2429

DOI: 10.3390/microorganisms11102429 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 28.09.2023. Verfasst von Elie Djenontin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dynamyc UPEC, EnvA, USC Anses, Faculté de Médecine de Créteil, 94010 Créteil, France. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Aspergillus flavus is a cosmopolitan mold with medical, veterinary, and agronomic concerns. Its morphological similarity to other cryptic species of the Flavi section requires molecular identification techniques that are not routinely performed. For clinical isolates of Aspergillus section Flavi, we present the molecular identification, susceptibility to six antifungal agents, and clinical context of source patients. (2)

Methods

One hundred forty fungal clinical isolates were included in the study. These isolates, recovered over a 15-year period (2001–2015), were identified based on their morphological characteristics as belonging to section Flavi. After the subculture, sequencing of a part of the β-tubulin and calmodulin genes was performed, and resistance to azole antifungals was screened on agar plates containing itraconazole and voriconazole. Minimum inhibitory concentrations were determined for 120 isolates by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution method. (3)

Results

Partial β-tubulin and calmodulin sequences analysis showed that 138/140 isolates were A. flavus sensu stricto, 1 isolate was A. parasiticus/sojae, and 1 was A. nomiae. Many of the isolates came from samples collected in the context of respiratory tract colonization. Among probable or proven aspergillosis, respiratory infections were the most frequent, followed by ENT infections. Antifungal susceptibility testing was available for isolates (n = 120, all A. flavus ss) from one hospital. The MIC range (geometric mean MIC) in mg/L was 0.5–8 (0.77), 0.5–8 (1.03), 0.125–2 (0.25), 0.03–2 (0.22), 0.25–8 (1.91), and 0.03–0.125 (0.061) for voriconazole, isavuconazole, itraconazole, posaconazole, amphotericin B, and caspofungin, respectively. Two (1.67%) isolates showed resistance to isavuconazole according to current EUCAST breakpoints with MICs at 8 mg/L for isavuconazole and voriconazole. One of these two isolates was also resistant to itraconazole with MIC at 2 mg/L. (4)

Conclusions

The present characterization of a large collection of Aspergillus belonging to the Flavi section confirmed that A. flavus ss is the predominant species. It is mainly implicated in respiratory and ENT infections. The emergence of resistance highlights the need to perform susceptibility tests on section Flavi isolates.

Schlagwörter

Stichwörter der Autor:innen

Aspergillus flavusAspergillus nomiaeAspergillus parasiticusAspergillus sojaeFlavi sectionantifungal resistancecryptic species

Autor:innen und Institutionen

  • Dynamyc UPEC, EnvA, USC Anses, Faculté de Médecine de Créteil, 94010 Créteil, France.
  • Service de Parasitologie-Mycologie, Hôpital Universitaire Mondor, AP-HP, 8 Rue du Général Sarrail, 94010 Créteil, France.
  • Laboratoire CERBA, 11 Rue de l'Équerre, 95310 Saint-Ouen-l'Aumône, France.
  • Family Hospital, 73 Nguyen Huu Tho, Hai Chau, Danang 55000, Vietnam.
  • Unité pédagogique de Dermatologie, Parasitologie, Mycologie, Ecole Nationale Vétérinaire Agroalimentaire et de l'Alimentation Nantes Atlantique, Oniris, 44300 Nantes, France.
  • Laboratoire de Parasitologie-Mycologie, CNR des Aspergilloses Chroniques-CHU de Bordeaux, INSERM U1045-Univ. Bordeaux, 33000 Bordeaux, France.

ORCID-Profile: Laurence Delhaes, Françoise Botterel, Eric Dannaoui

Zitieren

APA

Djenontin, E., Costa, J. M., Mousavi, B., Nguyen, L. D. N., Guillot, J., Delhaes, L., Botterel, F., & Dannaoui, E. (2023). The Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Aspergillus Section Flavi from Three French Hospitals. Microorganisms, 11(10), 2429. https://doi.org/10.3390/microorganisms11102429

Vancouver

Djenontin E, Costa JM, Mousavi B, Nguyen LDN, Guillot J, Delhaes L, et al. The Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Aspergillus Section Flavi from Three French Hospitals. Microorganisms. 2023;11(10):2429. doi:10.3390/microorganisms11102429

BibTeX
@article{Djenontin2023,
  author = {Djenontin, Elie and Costa, Jean-Marc and Mousavi, Bita and Nguyen, Lin Do Ngoc and Guillot, Jacques and Delhaes, Laurence and Botterel, Françoise and Dannaoui, Eric},
  title = {The Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Aspergillus Section Flavi from Three French Hospitals},
  journal = {Microorganisms},
  year = {2023},
  volume = {11},
  number = {10},
  pages = {2429},
  doi = {10.3390/microorganisms11102429}
}
Kostenlos starten →